CooperVision, a world leader in myopia control and management for children, has announced new seven-year findings from its pivotal MiSight® 1 day contact lens clinical trial. Twelve months ...

Caption The cornerstone of a comprehensive myopia management approach to be offered by CooperVision, MiSight 1 day is a daily wear, single use contact lens--the first and only FDA-approved product ...

Growth demonstrates the company’s commitment to advancing myopia management as the standard of care.